(Ala11,D-Leu15)-Orexin B (human) features alanine and D-leucine substitutions that refine receptor binding and stability. These modifications help probe the structural requirements for orexin receptor interactions. The peptide's altered sequence is used to study appetite regulation and neuropeptide signaling. Researchers apply it to map receptor-binding profiles and functional consequences in neuropeptide-mediated pathways.
CAT No: O02005
CAS No:532932-99-3
Synonyms/Alias:[Ala11,D-Leu15]-Orexin B;532932-99-3;(Ala11,d-leu15)-orexin b(human);[Ala11,D-Leu15]-Orexin B TFA;C120H206N44O35S;HB3407;DA-48928;FA109685;[Ala11,D-Leu15]-Orexin B (human) acetate;(Ala11,D-Leu15)-Orexin B (human) trifluoroacetate salt;RSGPPGLQGRAQRLLQASGNHAAGILTM (modifications: Met-28 = C-terminal amide);H-Arg-Ser-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Ala-Gln-Arg-Leu-D-Leu-Gln-Ala-Ser-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-NH2; H-RSGPPGLQG RAQRL(dL)QASGNHAAGILTM-NH2;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.